Table 3.
Target | mAb | Type |
---|---|---|
anti-CD20 antibody | rituximab | lymphoma, chronic lymphocytic leukemia |
anti-EGFR antibody | cetuximab | head and neck cancer and colorectal cancer |
anti-HER2 antibody | trastuzumab | HER2-positive metastatic breast cancer |
Abbreviations: EGFR, epidermal growth factor receptor; HER2, human epidermal growth factor-2.